Dual antiplatelet duration after left main PCI: patient needs elective surgery at 6 months post-stent

71M underwent unprotected left main PCI with a 4.0x15mm drug-eluting stent (Synergy EES) 5 months ago. SYNTAX score was 22 (low-intermediate). LV function normal. He now needs an elective right hemicolectomy for a cecal mass (biopsy: well-differentiated adenocarcinoma, no obstruction).

Current medications: Aspirin 81mg + ticagrelor 90mg BID, atorvastatin 80mg, metoprolol 25mg.

The dilemma:

ACC/AHA guidelines recommend minimum 12 months DAPT after left main PCI
Surgery requires stopping ticagrelor (bleeding risk)
But left main stent thrombosis is catastrophic and nearly always fatal
The surgeon wants to operate within 4-6 weeks
Can we shorten DAPT based on the TWILIGHT or TICO trial data?
Should we bridge with cangrelor or IV tirofiban perioperatively?

This is one of the highest-stakes decisions in interventional cardiology. My approach:

1. Can we shorten DAPT? The short answer is: not safely at 6 months for left main PCI. TWILIGHT and TICO both excluded left main lesions. The IDEAL-LM registry showed that left main stent thrombosis risk remains elevated for 12+ months, especially with bifurcation stenting.

2. My recommendation: Delay surgery to at minimum 9 months post-PCI if oncologically feasible. The COURAGE-type data for cecal adenocarcinoma without obstruction supports a 3-month delay being safe. I would discuss with oncology.

3. If surgery absolutely cannot wait:

Stop ticagrelor 5 days before surgery (per pharmacokinetics)
Continue aspirin throughout the perioperative period
Bridge with IV cangrelor starting 48 hours before surgery, stopping 1 hour before incision
Resume ticagrelor within 24-48 hours postoperatively via NG tube if needed
Ensure the surgical team has access to platelet transfusion

4. Perioperative monitoring:

Continuous telemetry for 72 hours post-op (stent thrombosis often presents as STEMI)
Serial troponins q8h for 48 hours
Low threshold for emergent angiography if any chest symptoms or hemodynamic instability

The cangrelor bridging strategy is supported by the BRIDGE trial, though this was not specifically for left main PCI. The half-life of cangrelor is only 3-6 minutes, making it ideal for perioperative management. Resume DAPT as soon as surgical hemostasis allows.

Agree with Dr. Mehta's approach. Adding our MGH institutional data:

We reviewed 14 left main PCI patients who required non-cardiac surgery within 12 months. Key findings:

3/14 required surgery before 9 months
All 3 were bridged with cangrelor
Zero stent thrombosis events in the bridged group
1 patient had a major bleed (retroperitoneal) requiring transfusion

One important nuance: The stent platform matters. This patient received a Synergy stent (bioabsorbable polymer). These have faster endothelialization compared to durable polymer DES (Xience, Resolute). Some emerging data from the MASTERCLASS registry suggests that bioabsorbable polymer stents may allow shorter DAPT, but this has NOT been validated for left main.

Bottom line: I would push for 9 months minimum. If forced to operate at 6 months: cangrelor bridge + aspirin continuation + aggressive post-op monitoring. And document, document, document the shared decision-making with the patient and surgical team.

From the surgical/trauma perspective, I want to add one practical consideration that often gets overlooked in these cardiac-surgery negotiations:

The anesthesia plan matters enormously. For a right hemicolectomy on a patient with recent left main PCI:

Neuraxial anesthesia is contraindicated if the patient is on any P2Y12 inhibitor within the clearance window
Plan for general anesthesia with invasive arterial monitoring
Have emergency PCI capability on standby (this may require scheduling the case at a hospital with a 24/7 cath lab)
Type and crossmatch for 4 units pRBC given the combined bleeding + antiplatelet risk

In Germany, our interdisciplinary tumor boards routinely include cardiology when a patient has recent coronary intervention. The joint decision is documented in the board minutes. I would strongly recommend the same approach here: get cardiology, oncology, surgery, and anesthesiology in one room before committing to a date.

3 Answers